Goldman Sachs’s Prenetics Global PRE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$3.23M Sell
168,733
-24,850
-13% -$459K ﹤0.01% 4277
2026
Q1
$3.74M Buy
193,583
+151,338
+358% +$2.82M ﹤0.01% 3972
2025
Q4
$665K Buy
+42,245
New +$615K ﹤0.01% 5421

Other funds holding PRE

Goldman Sachs's PRE Position: Q2 2026 in Review

Goldman Sachs reduced its Prenetics Global (PRE) stake by 13% in Q2 2026, selling an estimated $459K and leaving 168,733 shares worth $3.23M. The position accounts for ﹤0.01% of the portfolio, ranked #4277.

Goldman Sachs first reported a position in PRE in Q4 2025 and has held it in 3 quarters since. The position peaked at $3.74M in Q1 2026. 25 funds tracked by Wall St. Rank hold PRE as of Q2 2026.

  • Goldman Sachs held 168,733 shares of Prenetics Global worth $3.23M as of Q2 2026.
  • Goldman Sachs sold 24,850 Prenetics Global shares in Q2 2026, an estimated $459K.
  • Prenetics Global made up ﹤0.01% of Goldman Sachs's portfolio in Q2 2026, its #4277 holding.
  • Goldman Sachs first reported a position in Prenetics Global in Q4 2025 and has held it in 3 quarters since.
  • Goldman Sachs's Prenetics Global position peaked at $3.74M in Q1 2026.
  • 25 funds tracked by Wall St. Rank held Prenetics Global as of Q2 2026.

Based on Goldman Sachs's 13F filing for Q2 2026, filed 14 Aug 2026.